96 results
Page 2 of 5
8-K
EX-99.1
7thc3du1sxcpgo8atyht
4 May 21
Invitae Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volume in First Quarter of 2021
4:07pm
8-K
EX-4.1
d3e9t2z ua
8 Apr 21
Entry into a Material Definitive Agreement
4:29pm
8-K
EX-10.1
wjszn5
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K
EX-1.1
2ylcxswc98lci f9
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
ttz1rtpw r46sg
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
srz239u 8ix65u3pcib9
20 Jan 21
Prospectus supplement for primary offering
4:24pm
8-K
EX-99.2
ch8uj4z u3hr
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
1khm9o
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
0cm16w
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
noj1ezvzk5ef1fcl0btb
28 Aug 20
Prospectus supplement
4:31pm
425
9oa7ulsn
24 Jun 20
Business combination disclosure
5:11pm